Swiss BioQuant is a bioanalytical contract research organization (CRO) specialized in LC-MS/MS and ligand-binding assays and dedicated to scientific excellence. With a deep understanding of customer requirements, Swiss BioQuant is the bioanalytical laboratory of choice for pharmaceutical and biotechnology companies demanding scientific excellence, uncompromised quality, timeliness, honest and open communications. Swiss BioQuant offers customized LC-MS/MS and ligand binding assay method development, validation and sample analysis in a 21 CFR part 11 compliant environment for small and large molecules. The high level of our services allows us to effortlessly keep pace with the constantly increasing quality demands of renowned pharmaceutical groups, both in content and in documentation. Important prerequisites for our excellent service and quality standards (GLP) are represented by our continuous investments into employee training, documentation and instrumentation. Continuous audits or inspections throughout years convincingly document the success of our efforts in these fields. An automated data evaluation and reporting system as well as a validated electronic archiving system facilitates a reliable data management.
Company Details
- Employees
- 39
- Founded
- -
- Address
- Kägenstrasse 18, Reinach,basel-Landschaft 4153,switzerland
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- swissbioquant.com
- Keywords
- LC-MS/MS, ligand-binding assays, ADA assays, TK assays, Cell-based assays, Orbitrap, Metabolites identification, BA, LBA, Biomarkers.
- HQ
- Reinach, Basel-Landschaft
Swiss Bioquant Ag Questions
Swiss Bioquant Ag's website is swissbioquant.com
Swiss Bioquant Ag's LinkedIn profile is https://ch.linkedin.com/company/swissbioquant
Swiss Bioquant Ag has
39 employees.
View email and phone details for 39
employees at Swiss Bioquant Ag.
Swiss Bioquant Ag's industry is
Biotechnology Research
Swiss Bioquant Ag's top competitors are
Swissmedic,
Lonza,
Idorsia Pharmaceuticals Ltd,
Actelion (Now Janssen Pulmonary Hypertension),
Debiopharm,
Pentapharm,
Bioreba Ag,
Novartis,
Zenith Therapeutics,
Celerion.
Swiss Bioquant Ag's categories are Biotechnology Research
Swiss Bioquant Ag's founding year is 2007
